Partner Content Partner Content Explore New Strategies to Maintain a Global Pharmacovigilanc... Drug Safety 2018
Partner Content Partner Content Attendee List Released for SMi’s 9th Annual RNA Therapeutics RNA Therapeutics
News BI drug named Promising Innovative Medicine in mesothelioma Boehringer Ingelheim is the latest company to gain a Promising Innovative Medicine (PIM) status in the UK for one of its drugs.
Views & Analysis How can the UK improve in clinical research? A biotech persp... The UK is a great place for early-stage research – but NHS red tape and market access remain major barriers.
Views & Analysis Pharma and med device sectors being forced into Hard Brexit ... Brexit is already forcing parts of the medical device sector to leave the UK – will pharma have to follow?
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
